Fymskina
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fymskina, covering 2026-02-24 to 2026-02-24. Get the full timeline:
Most recent: EMA Authorised: Fymskina (ustekinumab) — Formycon AG
1 regulatory and trial event tracked for Fymskina, covering 2026-02-24 to 2026-02-24. Get the full timeline:
Most recent: EMA Authorised: Fymskina (ustekinumab) — Formycon AG